
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing aloe barbadensis leaf extract, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing aloe barbadensis is listed. Products containing it are filed in the directory as over-the-counter monograph drugs, unapproved drugs and homeopathic products, in cream, liquid, patch, ointment and stick forms. None of the listed products containing aloe barbadensis is in suppository form.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Aloe vera is a plant-derived soothing and moisturizing agent that compounding pharmacies include in topical gels, creams and oral rinses by prescription.
Aloe vera is a succulent plant. Its clear inner-leaf gel has been applied to the skin for centuries and contains more than 75 identified substances, including vitamins A, C and E, enzymes, minerals, sugars, amino acids and salicylic acid. The yellow latex just under the leaf rind is different: it contains anthraquinones, which are strong laxatives. No FDA-approved prescription drug lists aloe vera as its sole active ingredient. It appears in hundreds of over-the-counter and cosmetic products such as burn gels, sunscreens and hand sanitizers, and the FDA removed aloe latex from over-the-counter laxatives in 2002 for lack of safety data. A prescriber might order a compounded preparation using aloe vera gel as the base for another active ingredient or as a moisturizing vehicle for irritated skin. Compounded preparations are not FDA-approved and require a prescription.
Because no manufactured drug uses aloe vera as its sole active ingredient, there is no FDA label and no boxed warning. On the skin, aloe gel is generally well tolerated; occasional burning, itching, rash and eczema have been reported. Do not use it if you have reacted to aloe before. Taken by mouth, aloe latex causes abdominal pain, cramps and diarrhea, oral leaf extracts have been linked to rare liver injury that resolved after stopping, and latex overuse may add to digoxin side effects. NCCIH says oral aloe may be unsafe in pregnancy and breastfeeding; LactMed says aloe latex should not be used while breastfeeding, but topical gel on cracked nipples is acceptable if washed off before nursing. If a topical preparation stings or causes a rash, stop and talk to your prescriber or pharmacist.
Aloe vera leaf yields two materials: the inner gel, rich in water, polysaccharides, vitamins, enzymes and salicylic acid, and the rind latex, which contains anthraquinone laxatives. In vitro and animal work suggests anti-inflammatory, antiproliferative and hepatoprotective activity, and NCCIH summarizes small clinical studies suggesting topical gel may shorten burn healing and reduce burn pain, with limited evidence for acne, lichen planus, psoriasis, oral submucous fibrosis, radiation dermatitis and denture-related mouth sores. No pharmacokinetic data for topical gel are available in the sources. No manufactured product carries a labeled indication for aloe as a sole active; it is a cosmetic and OTC ingredient. Prescribers have ordered compounded aloe-based vehicles for radiation dermatitis and oral mucosal conditions, where NCCIH describes the evidence base as small, and topical gel for cracked nipples in nursing mothers, where LactMed cites conflicting meta-analyses. Vehicle and concentration are per prescriber. Oral leaf extracts carry a LiverTox likelihood score of B for idiosyncratic hepatocellular injury appearing 3 to 24 weeks after starting; rechallenge should be avoided. Topical use needs no monitoring beyond observation for contact dermatitis. Aloe vera is not a controlled substance.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository